S

Segal Trials | Behavioral Clinical Research, Inc.

Research site

(Unclaimed)

Location

14211 Commerce Way, Miami Lakes, Florida, United States of America

Site insights

Top conditions

Top treatments

SEP-363856

Buprenorphine

MK-8189

KarXT

STS101

MK-8189-008

Psilocybin

AEF0117

JZP150

Parent organization

This site is a part of Segal Trials

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 10 total trials

A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (ARISE)

This is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequ...

Enrolling

Schizophrenia

Drug: Xanomeline and Trospium Chloride Capsules

Drug: Placebo

An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication

An Extension study to a clinical study that will continue to evaluate the effectiveness and safety of SEP-363856 in people with schizophrenia that sw...

Invitation-only

Schizophrenia

Drug: SEP-363856